Agilent Technologies has announced that its LC?MS systems, including the 6100 Series single quadrupole and 6400 Series triple quadrupole systems are now manufactured under ISO 13485 certification.
Agilent Technologies has announced that its LC–MS systems, including the 6100 Series single quadrupole and 6400 Series triple quadrupole systems are now manufactured under ISO 13485 certification. This is an internationally recognized standard of quality management for the design and manufacture of medical devices.
“This is just the latest step that Agilent has taken to clear the way for use of our life science tools in the clinic,” said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division. “We’re also in talks with the FDA about requirements for clearing a number of our platforms, and we’re being very methodical and deliberate about this.”
John Fjeldsted, Agilent general manager, LC–MS, noted that this additional validation on top of their own high standards of quality design and manufacturing would add value to their systems and their use in the clinic.
For more information, visit www.agilent.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.